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Abstract: Cross-sectional studies have reported positive relationships between serum 
lutein concentrations and higher physical activity levels. The purpose of the study was to 
determine whether increasing plasma lutein levels increases physical activity. Forty-four 
older adults (BMI, 25.3 ± 2.6 kg/m2; age, 68.8 ± 6.4 year) not meeting Australian physical 
activity guidelines (150 min/week of moderate to vigorous activity) were randomized to 
consume capsules containing 21 mg of lutein or placebo with 250 mL of full-cream milk 
per day for 4 weeks and encouraged to increase physical activity. Physical activity was 
assessed by self-report, pedometry and accelerometry (daily activity counts and sedentary 
time). Exercise self-efficacy was assessed by questionnaire. Thirty-nine participants 
competed the study (Lutein = 19, Placebo = 20). Lutein increased plasma lutein 
concentrations compared with placebo (p < 0.001). Absolute and percentage changes in 
plasma lutein were inversely associated with absolute (r = −0.36, p = 0.03) and percentage 
changes (r = −0.39, p = 0.02) in sedentary time. Percentage change in plasma lutein was 
positively associated with the percentage change in average daily activity counts (r = 0.36, 
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p = 0.03). Exercise self-efficacy did not change (p = 0.16). Lutein increased plasma lutein, 
which was associated with increased physical activity and reduced sedentary time in older 
adults. Larger trials should evaluate whether Lutein can provide health benefits over the 
longer term. 
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1. Introduction 
The populations of many developed countries are ageing. Ageing predisposes to physical and 
mental disability, but this can be attenuated through regular physical activity. Regular physical activity 
can maintain physical function during ageing through reductions in the loss of bone tissue [1], 
maintenance of cartilage [2] and skeletal muscle mass [3], and can also assist in maintaining mental 
function by improving cognitive performance [4]. However, despite a range of public health initiatives 
to increase population levels of physical activity, calls for communities to engage more in physical 
activity have in large part gone unheeded, with only ~40% of people engaging in sufficient physical 
activity to promote or maintain good health [5]. Clearly, alternative approaches are required to assist 
people in increasing their levels of physical activity. 
Data from cross-sectional studies have demonstrated positive associations between serum levels of 
the carotenoids lutein and zeaxanthin and physical activity, such that higher serum lutein and 
zeaxanthin are associated with higher levels of physical activity [6,7]. It has been implied that the 
higher serum lutein and zeaxanthin are a result of increased physical activity [6], but because these 
studies are cross-sectional they are unable to determine causality, and it is possible that physical 
activity levels might be higher due to higher circulating lutein and zeaxanthin concentrations (i.e., 
higher lutein and zeaxanthin might increase physical activity). Such a hypothesis has not previously 
been tested.  
The aim of this study was to determine whether an increase in plasma lutein concentration from 
consuming lutein capsules with full-fat milk as a vehicle, increased physical activity in older adults. 
2. Experimental Section 
2.1. Participants 
Forty four older adults (55–80 years) who were not obese (BMI 18.5–29.9 kg/m2) and who by  
self-report did not meet current Australian national physical activity guidelines (i.e., not undertaking at 
least 150 min of moderate to vigorous activity per week) were recruited for the study (Figure 1). 
Participants were excluded if they were not weight-stable or had changed medication in the last  
12 weeks, if they had diabetes, lactose intolerance or allergy to cow’s milk protein, Coeliac disease, an 
acute or terminal illness, history of smoking in the last 12 months, moderate or severe cognitive 
impairment, or consumed more than four alcoholic drinks per day. Prior to participation all volunteers 
were screened by a qualified medical practitioner, and undertook an exercise stress test. They were 
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excluded if they had a medical condition that might be exacerbated by exercise, if exercise might place 
them at risk, or if they had a condition that might limit exercise training. 
Figure 1. CONSORT Diagram of participant flow from recruitment to analysis of the study. 
 
2.2. Protocol 
The study comprised a randomized double-blind placebo-controlled intervention trial of 5 weeks 
duration. After a 1 week run-in period, participants were allocated to consume 3 capsules per day 
containing either 7 mg of lutein and also 0.3 mg of zeaxanthin (total of 21 mg/day of lutein and  
0.9 mg/day of zeaxanthin; Lutein) or 3 placebo capsules per day (154.5 mg microcrystalline cellulose, 
154.5 mg lactose, 4 mg brown cacao and 2 mg safflower colour per capsule; Placebo). The capsules 
were all similar in appearance and were consumed with 250 mL of full cream milk (3%–4% fat). Full 
cream milk was used to provide a vehicle to promote better absorption of the fat soluble carotenoids. 
Allocation to treatment was via minimisation [8], aimed at minimising differences in gender, age, and 
current levels of physical activity (assessed by pedometry in the week prior to treatment allocation). 
Participants were asked to consume the milk and capsules at the same time every day, preferably in the 
morning. After 1 week of supplementation all participants were encouraged to try and achieve at least 
150 min/week of moderate to vigorous activity in accordance with the national physical activity 
guidelines for Australian adults [9]. Participants were also asked to limit their consumption of 
carotenoid rich foods during the study. Data were collected between May 2011 and May 2012. 
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Physical activity levels were assessed by pedometry throughout the study period and by 
accelerometry during the one week run-in prior to commencement of supplementation and during the 
final week of supplementation. Exercise self-efficacy was assessed by questionnaire [10] at the start of 
the run-in week (Week −1) and again after one week of supplementation, but prior to participant being 
encouraged to undertake physical activity, in order to assess any effects of the supplements on exercise 
self-efficacy without any potential confounding effects of physical activity participation. Participants 
were then encouraged to commence regular physical activity in accordance with Australian national 
physical activity guidelines for adults [9]. Physical activity levels were assessed again by 
accelerometry during the final week and exercise self-efficacy was assessed at the end of the final 
week. A diagram of the protocol is provided in Figure 2. The trial was approved by the Human 
Research Ethics Committee of the University of South Australia (21 February 2011) and was 
registered on the Australia New Zealand Clinical Trials Register (ACTRN12611000248965, 7 March 
2011). Written informed consent was obtained from all participants. 
Figure 2. Study design. 
 
2.3. Physical Activity Program 
Information was provided to participants on the benefits of regular physical activity for maintaining 
and promoting health and participants were encouraged to achieve 150 min of moderate to vigorous 
physical activity per week in line with the national physical activity guidelines for Australian  
adults [9] which promote 30 min of moderate-intensity physical activity on most days, increased 
incidental activity, and vigorous exercise where possible. Participants were offered advice to achieve 
these guidelines by undertaking regular walking and/or jogging exercise, but were free to decide how 
much exercise they did each week. 
2.4. Outcome Assessments 
Participants maintained exercise diaries in which they recorded the duration of exercise undertaken 
each day during Weeks 1 to 4 to allow for subsequent calculation of self-reported physical activity. 
Accelerometry (7164 ActiGraph, MTI Health Services, Fort Walton Beach, FL, USA) was used over a 
7−day period (5 week days and 2 weekend days) during the run-in and again in the final week of 
intervention to ascertain the amount of sedentary activity, light physical activity and moderate-vigorous 
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physical activity undertaken. Cut-points for activity levels using the accelerometer data were 
determined in accordance with definitions applied to accelerometer data in the National Health and 
Nutrition Examination Survey [11]. Participants were also provided with pedometers and asked to 
record the number of steps taken each day throughout the study. 
Exercise self-efficacy was assessed using a validated questionnaire portraying different levels of 
exercise task demands against which participants rated the strength of their belief in their ability to 
perform their exercise routine regularly using a 100 point scale [10]. The higher the score the greater 
the exercise-self efficacy. 
Fasting blood samples were taken at the first visit (before supplementation) and at the end of the 
study. Samples were frozen at −80 °C until subsequent analysis in October 2012. Plasma lutein and 
zeaxanthin concentrations in these samples were measured by High Performance Liquid 
Chromatography using the method of Jensen et al. [12]. Total cholesterol was measured using an 
enzymatic method using a Seimens Advia 2400 analyser. 
2.5. Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics 21 (SPSS, Chicago, IL, USA) and 
statistical significance was set at p < 0.05. Data were checked for normality prior to analysis and are 
presented as mean ± standard deviation (SD). Baseline measurements were compared between groups 
using independent samples t-tests. Correlation analysis using Pearson’s correlation coefficient was 
used to determine relationships between the changes in plasma lutein and zeaxanthin concentrations 
and changes in measures of physical activity. To determine the effects of the treatment and time of 
measurement on the measured variables, repeated measures analysis of variance and co-variance were 
used. Baseline cholesterol levels were used as a covariate as lutein is fat soluble and could be 
sequestered by cholesterol. 
3. Results 
Thirty-nine participants completed the study (Lutein n = 19, Placebo n = 20; 17 males, 22 females, 
Age: 67.5 ± 6.6 year, BMI 25.4 ± 2.6 kg/m2). Five participants withdrew from the study for personal 
reasons. There were no significant gender x treatment x time interactions (p > 0.29) so genders were 
pooled for analysis. Compliance with consuming the capsules was high and not different between 
treatments (Lutein 95.8 ± 4.1%, Placebo 95.1 ± 6.4%; p = 0.6). 
There was no difference in baseline plasma lutein and zeaxanthin levels, cholesterol levels, average 
activity counts and steps per day, time spent undertaking sedentary, light physical activity and 
moderate to vigorous activity and exercise self-efficacy between treatments groups (p > 0.1, Table 1). 
Participants allocated to the lutein treatment weighed slightly less than those allocated to the placebo 
treatment at baseline.  
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Table 1. Baseline characteristics for participants randomized to consume lutein or placebo 
capsules with milk. 
Values are mean ± SD; BMI, body mass index; ** significantly different value between treatment groups at 
baseline (p < 0.001). 
Lutein significantly increased plasma lutein and zeaxanthin concentrations during the study, and 
there was no change in the placebo group (p < 0.001, treatment × time; Table 2). The absolute change 
in plasma lutein concentration was not significantly associated with the absolute change in average 
daily activity counts (r = 0.29, p = 0.08). However, when expressed as a percentage, the percentage 
change in plasma lutein concentration was positively associated with the percentage change in average 
activity counts (r = 0.36, p = 0.03), such that participants who experienced a greater percentage 
increase in plasma lutein concentration had a greater increase in activity counts (Figure 3). Thus a 
doubling of plasma lutein concentration was associated with a 26% increase in average daily activity 
counts. One participant had a greater than 300% increase in average daily activity counts; excluding 
this person’s data from the correlation analysis did not alter the relationship between the percentage 
change in plasma lutein concentration and the percentage change in average daily activity counts. 
Changes in plasma zeaxanthin concentrations were not associated with changes in activity counts when 
expressed as either absolute values (r = 0.20, p = 0.25), or as percentage change (r = 0.18,  
p = 0.30). 
Characteristic Lutein Placebo 
Age (years) 67.7 ± 7.7 67.4 ± 5.5 
BMI (kg/m2) 24.9 ± 2.5 25.8 ± 2.6 
Weight (kg) ** 70.3 ± 12.5 73.1 ± 10.6 
Plasma lutein (μg/dL) 10.3 ± 2.5 10.1 ± 3.6 
Plasma zeaxanthin (μg/dL) 4.3 ± 0.7 4.5 ± 0.7 
Plasma lutein + zeaxanthin (μg/dL) 14.6 ± 2.9 14.6 ± 4.1 
Cholesterol (mmol/L) 5.0 ± 0.8 4.8 ± 0.9 
Accelerometer counts per day 235,292 ± 82,693 273,760 ± 85,018 
Sedentary time (min/day) 235 ± 61 219 ± 46 
Light physical activity (min/day) 301 ± 88 341 ± 76 
Moderate to vigorous physical activity (min/day) 22 ± 14 24 ± 18 
Steps per day 7685 ± 2234 7632 ± 2092 
Exercise self-efficacy 1204 ± 345 1073 ± 425 
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Table 2. Change in values following 4 weeks of supplementation and 3 weeks of physical 
activity participation. 
Values are mean ± SD Significant time by treatment effect ** p < 0.001, * p = 0.04. 
The change in plasma lutein concentration was inversely related to the change in the time per day 
(in minutes) that was spent being sedentary (r = −0.36, p = 0.03), such that those who experienced 
greater increases in plasma lutein concentrations experienced greater reductions in the time spent 
engaged in sedentary activities. For every 1 μg/dL increase in plasma lutein concentration there was on 
average a 1.9 min decrease in time spent being sedentary. This relationship was strengthened slightly 
when expressed as percentage change in time spent in sedentary activity relative to percentage change 
in plasma lutein (r = −0.39, p = 0.02), whereby a doubling of plasma lutein concentration was 
associated with a 10% decrease in time spent being sedentary (Figure 4). There was a trend for an 
inverse relationship between the change in plasma zeaxanthin concentration and time spent in 
sedentary activity (absolute change, r = −0.30, p = 0.07; percentage change, r = −0.32, p = 0.06). 
Figure 3. Relationship between percentage change in plasma lutein concentration and 
percentage change in average activity counts determined using accelerometry. 
 
Outcome Lutein Placebo 
Weight (kg) 0.04 ± 1.12 0.02 ± 0.66 
Plasma lutein (μg/dL) ** 13.9 ± 5.7 0.09 ± 2.5 
Plasma zeaxanthin (μg/dL) * 0.58 ± 0.50 0.09 ± 0.88 
Plasma lutein + zeaxanthin (μg/dL) ** 14.5 ± 5.9 0.2 ± 2.7 
Counts per day 49,995 ± 77,384 8528 ± 75,691 
Sedentary time (min/day) −3.4 ± 41.6 17.7 ± 42.8 
Light physical activity (min/day) 19.0 ± 46.9 −14.2 ± 70.8 
Moderate to vigorous physical activity (min/day) 8.6 ± 15.2 7.1 ± 17.2 
Steps per day 1652 ± 1602 948 ± 2054 
Exercise self-efficacy  43 ± 160 87 ± 230 
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Figure 4. Relationship between percentage change in plasma lutein concentration  
and percentage change in minutes spent engaged in sedentary activity determined  
using accelerometry. 
 
Average activity counts increased by the end of the study period (p = 0.03), but with no difference 
in the increase between treatments (p = 0.11, p = 0.08 when controlling for cholesterol). The number 
of steps taken per day increased over the study period (p < 0.001), but with no difference  
between treatment groups (p = 0.24). There was no difference in self-reported minutes spent  
engaged in exercise between treatments during the three weeks of the exercise program (Lutein,  
41.1 ± 21.3 min/day; Placebo, 32.0 ± 18.6 min/day; p = 0.16). Body weight and exercise  
self-efficacy did not change during the study (p = 0.94 and p = 0.16, respectively). Time spent engaged 
in light physical activity did not change significantly during the intervention (time, p = 0.81;  
time × treatment, p = 0.10). Time spent engaging in moderate to vigorous activity increased during the 
intervention period (p = 0.006), but with no difference in the magnitude of increase between treatments 
(p = 0.78). Sedentary time did not change significantly during the intervention (time, p = 0.32;  
time × treatment, p = 0.14). There was no difference between treatments in the other outcomes when 
controlling for cholesterol. 
4. Discussion  
The main finding of the present study was that increases in plasma lutein concentration correlated 
positively with changes in daily activity and inversely with changes in sedentary time, such that 
individuals who achieved the greatest increases in plasma lutein concentrations achieved the greatest 
increases in average daily activity counts and decreases in time spent engaged in sedentary activities. 
These changes may be important, given that low physical activity and increased time engaged in sedentary 
activity are associated with increases in cardio-metabolic disease risk (e.g., type 2 diabetes) [13] and 
mortality [14], particularly since supplementation with lutein increased average plasma lutein 
concentration by 135%, and a doubling of plasma lutein was on average associated with a 26% 
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increase in activity counts and a 10% reduction in sedentary time. The average plasma lutein and 
zeaxanthin concentrations at baseline were similar to those reported in other studies [7,15–18]. 
The average daily activity counts recorded in this study were similar to those reported previously in 
older adults using accelerometry [19]. While there was an overall tendency for a greater increase in 
most measures of physical activity and a greater reduction in sedentary time in the participants who 
consumed lutein compared with those who consumed the placebo, these differences did not reach 
statistical significance (p = 0.08). Given the statistically significant relationship between the increase 
in plasma lutein concentrations and increases in physical activity and decreases in sedentary time, it 
seems that the high variance in the increase in physical activity and reduction in sedentary time overall 
may have been related to the high variability in increases in plasma lutein. There is evidence that lutein 
absorption varies considerably depending on the food matrix, and is particularly influenced by the 
amount of fat consumed at the same time, with higher fat intake promoting greater lutein 
bioavailability [20,21]. Thus, while the supplements were consumed with full-cream milk in an effort 
to increase absorption of the lutein, there was still considerable variability in the bioavailability, 
possibly in part due to the relatively low fat content of the milk and the influence of other foods 
consumed around the same time as the supplements. Strategies to increase the bioavailability of lutein 
might therefore promote increases in physical activity and reductions in sedentary time. 
While this study provided evidence that lutein-milk supplementation can increase physical activity 
levels and reduce sedentary time, with the magnitude of change being associated with the magnitude of 
increase in plasma lutein concentration, the mechanism by which lutein elicits these effects is not clear. 
Lutein is able to cross the blood-brain barrier [22] and therefore has the potential to alter neural 
processes within the brain. Indeed, lutein consumption has previously been shown to be associated 
with cognitive performance in older women [23] and, as a result, we hypothesised that lutein might 
alter cognitions related to exercise behaviour and thus potentially increase engagement in physical 
activity. Exercise self-efficacy reflects a person’s belief that they will be able to engage in exercise, 
and has been shown in previous studies to be related to physical activity levels in older adults [19]. 
However, there was no change in exercise self-efficacy scores during the study period and there was 
no relationship between changes in exercise self-efficacy scores and changes in physical activity, 
indicating that in this study, the relationship between plasma lutein concentration and changes in 
physical activity and/or sedentary time were not mediated by changes in exercise self-efficacy. Future 
studies should seek to evaluate the mechanism by which an increase in plasma lutein concentration 
may increase physical activity and reduce sedentary time. 
5. Conclusions 
The current study provides preliminary evidence that the consumption of lutein increases plasma 
lutein concentrations, and that this increase is associated with increases in activity and reductions in 
time spent engaged in sedentary activities. Further evaluation of the potential for lutein to increase 
physical activity and reduce sedentary activity in older adults should be undertaken in larger,  
longer-term studies which evaluate the potential health benefits associated with these changes in 
physical activity and sedentary behaviours. 
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